FDA
approval
· 2022-01-07
FDA Approved: QUVIVIQ — Original Application (Idorsia Pharmaceuticals Ltd)
Summary
FDA approves QUVIVIQ (daridorexant) from Idorsia as an Original Application for treating insomnia in adults.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for QUVIVIQ (DARIDOREXANT)